Exact Mass: 452.9857

Exact Mass Matches: 452.9857

Found 28 metabolites which its exact mass value is equals to given mass value 452.9857, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dichlorochromopyrrolate

3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid

C22H13Cl2N3O4 (453.0283)


   

Copper gluconate

copper (ii) gluconate, min. 98

(C6H11O7)2. Cu (453.0306)


Same as: D02395

   

3-hydroxyguanfacine glucuronide

(2R,3R,4R,5S,6R)-6-{3-[(carbamimidoyl-C-hydroxycarbonimidoyl)methyl]-2,4-dichloro-5-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H17Cl2N3O9 (453.0342)


3-hydroxyguanfacine glucuronide is a metabolite of guanfacine. Guanfacine (brand name Tenex, and the extended release Intuniv) is a sympatholytic. It is a selective α2A receptor agonist. These receptors are concentrated heavily in the prefrontal cortex and the locus coeruleus, with the potential to improve attention abilities via modulating post-synaptic α2A receptors in the prefrontal cortex. (Wikipedia)

   

[2,6'-Bibenzothiazole]-7-sulfonic acid, 2'-(4-aminophenyl)-6-methyl-

2-[2-(4-aminophenyl)-1,3-benzothiazol-6-yl]-6-methyl-1,3-benzothiazole-7-sulfonic acid

C21H15N3O3S3 (453.0276)


   

Copper(II) gluconate

copper(2+) ion bis(2,3,4,5,6-pentahydroxyhexanoate)

C12H22CuO14 (453.0306)


It is used as a food additive

   
   
   
   

3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(3-chloro-1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride

3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(3-chloro-1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride

C16H13Cl3F3N5O (453.0138)


   

Copper gluconate

copper (ii) gluconate, min. 98

C12H22CuO14 (453.0306)


   

terbium nitrate, hexahydrate

terbium nitrate, hexahydrate

H12N3O15Tb (452.9522)


   
   

(6S)-3,10-Dibromo-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine

(6S)-3,10-Dibromo-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine

C21H13Br2NO (452.9364)


   

1-Benzyl-3-Methylimidazolium Bis((Trifluoromethyl)Sulfonyl)Imide

1-Benzyl-3-Methylimidazolium Bis((Trifluoromethyl)Sulfonyl)Imide

C13H13F6N3O4S2 (453.0252)


   

4-Bromo-2-(tributylstannyl)thiazole

4-Bromo-2-(tributylstannyl)thiazole

C15H28BrNSSn (453.0148)


   

3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

C21H13Br2NO (452.9364)


   

dichlorobis(ethylenediamine)iridium chloride

dichlorobis(ethylenediamine)iridium chloride

C4H16Cl4IrN4 (452.9758)


   

4-Bromo-3-(Carboxymethoxy)-5-[3-(Cyclohexylamino)phenyl]thiophene-2-Carboxylic Acid

4-Bromo-3-(Carboxymethoxy)-5-[3-(Cyclohexylamino)phenyl]thiophene-2-Carboxylic Acid

C19H20BrNO5S (453.0245)


   

Cefazolin(1-)

Cefazolin(1-)

C14H13N8O4S3- (453.0222)


A cephalosporin carboxylic acid anion having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and (1H-tetrazol-1-ylacetyl)amino side-groups, formed by proton loss from the carboxy group of cefazolin.

   

{5-[3-(2,4-Dichloro-benzyloxy)-benzylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic acid

{5-[3-(2,4-Dichloro-benzyloxy)-benzylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic acid

C19H13Cl2NO4S2 (452.9663)


   

3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid

3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid

C22H13Cl2N3O4 (453.0283)


   

[2,6-Bibenzothiazole]-7-sulfonic acid, 2-(4-aminophenyl)-6-methyl-

[2,6-Bibenzothiazole]-7-sulfonic acid, 2-(4-aminophenyl)-6-methyl-

C21H15N3O3S3 (453.0276)


   

3-hydroxyguanfacine glucuronide

3-hydroxyguanfacine glucuronide

C15H17Cl2N3O9 (453.0342)


   

2'-Deoxycytidine-5'-diphosphate (trisodium)

2'-Deoxycytidine-5'-diphosphate (trisodium)

C9H12N3Na3O10P2 (452.9691)


2'-Deoxycytidine-5'-diphosphate (dCDP) trisodium is an endogenous metabolite. 2'-Deoxycytidine-5'-diphosphate (dCDP) trisodium is an endogenous metabolite.

   

NDI-091143

NDI-091143

C20H14ClF2NO5S (453.0249)


NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay), a Ki of 7.0 nM and a Kd of 2.2 nM. NDI-091143 inhibits ACLY catalysis allosterically, by stabilizing large conformational changes in the citrate domain that indirectly block the binding and recognition of citrate[1].

   

16,17-dimethoxy-14-(trichloromethyl)-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,15,17,19-heptaene

16,17-dimethoxy-14-(trichloromethyl)-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,15,17,19-heptaene

C21H18Cl3NO4 (453.0301)


   

(14s)-16,17-dimethoxy-14-(trichloromethyl)-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,15,17,19-heptaene

(14s)-16,17-dimethoxy-14-(trichloromethyl)-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,15,17,19-heptaene

C21H18Cl3NO4 (453.0301)